Paragon Medical, Inc. Sustainability Profile
Paragon Medical, Inc., a leading name in the medical device industry, is headquartered in the United States, with significant operations across North America and Europe. Founded in 1991, the company has established itself as a trusted partner in the design and manufacturing of innovative surgical instruments and implantable devices. Paragon Medical's core offerings include custom surgical kits, advanced packaging solutions, and precision-engineered components, all tailored to meet the unique needs of healthcare providers. Their commitment to quality and innovation has positioned them as a key player in the market, recognised for their exceptional service and expertise. With a focus on enhancing patient outcomes, Paragon Medical continues to achieve notable milestones, solidifying its reputation as a leader in the medical manufacturing sector.
DitchCarbon Score
How does Paragon Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Rubber and Plastic Products industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Paragon Medical, Inc.'s score of 22 is higher than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Paragon Medical, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of AMETEK, Inc., which may influence its climate commitments and reporting practices. As of now, Paragon Medical has not established any documented reduction targets or initiatives related to carbon emissions. The lack of specific data suggests that the company may still be in the early stages of developing its climate strategy or reporting framework. Given its affiliation with AMETEK, Inc., any potential climate commitments or emissions data may be inherited from this parent company. However, no specific emissions data or reduction targets have been cascaded from AMETEK, Inc. to Paragon Medical at this time. In summary, while Paragon Medical, Inc. is part of a larger corporate family, it currently lacks detailed emissions reporting and defined climate commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|
| Scope 1 | 28,400,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 98,500,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - |
How Carbon Intensive is Paragon Medical, Inc.'s Industry?
How Carbon Intensive is Paragon Medical, Inc.'s Location?
Paragon Medical, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Paragon Medical, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
